 prevent treatment pregnancy-associ hypertens last year high blood pressur BP pregnanc hypertens pregnanc categori preeclampsia-eclampsia chronic hypertens caus preeclampsia-eclampsia hypertens renal diseas transient late hypertens gestat hypertens preeclampsia associ hypertens proteinuria edema account hypertens disord pregnanc major caus fetal matern morbid mortal preeclampsia caus hypertens clinic ground difficult lack specif test differenti diagnosi vascular resist primari caus preeclampsia variabl hemodynam profil high cardiac output normal fill pressur high system vascular resist investig imbal vasodil vasoconstrictor eicosanoid platelet activ respons peptid alter prostacyclin ratio matern uteroplacent vascular bed local platelet activ vasoconstrict placent insuffici fetal distress recent evid fetal umbil placent circul site primari vascular injuri low-dos aspirin prevent preeclampsia excess matern partial inhibit fetal therapeut valu treatment sever hypertens pregnanc import cardiac failur cerebrovascular accid mother need pharmacolog therapi mild hypertens formal studi avail pharmacolog treatment instanc matern fetal risk treatment preeclampsia hydralazin nifedipin deliveri applic labetalol diazoxid effect hypertens emerg life-threaten hypertens convent therapi indic use sodium nitroprussid chronic hypertens alpha-methyldopa treatment choic ineffect hydralazin beta-block suitabl effect safeti molecul elus